about
Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancersA novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cellsHigh level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).Histologic and systemic prognosticators for local control and survival in margin-negative transoral laser microsurgery treated oral cavity squamous cell carcinoma.Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma.Immune suppression in head and neck cancers: a reviewMolecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinomaIn Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.Role of abnormal Langerhans cells in oral epithelial dysplasia and oral squamous cell carcinoma: A pilot study.PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?Promising systemic immunotherapies in head and neck squamous cell carcinoma.Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.Immunotherapy in head and neck cancer: current practice and future possibilities.Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.The current state of head and neck cancer gene therapy.Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.Mononuclear phagocytes in head and neck squamous cell carcinoma.Eosinophils and oral squamous cell carcinoma: a short reviewClinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.What are regulatory T cells (Treg) regulating in cancer and why?Immunotherapy for head and neck cancer patients: shifting the balance.Immune alterations and immunotherapy prospects in head and neck cancer.Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer.Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck.Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients.CD4+ T helper responses in squamous cell carcinoma of the head and neck.T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer.Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma.T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma.Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towa
P2860
Q28387330-067B626A-6EBB-4818-80BC-D3A919B1B70FQ28476155-6EB2B82B-BA4A-4F13-BB9F-ADB058F67501Q33597525-C2C1D8CC-DC82-4F09-AC6E-F4E3FAE0230AQ33641504-847FD798-F4D2-4868-B703-915FFB22CE51Q33740789-A94969D3-85CE-407B-BF64-AA18C57A12C9Q33772810-68F25409-145F-4D48-BC95-1AF2390290DCQ33820247-9B36747E-E603-4C9A-9B24-36BA208E1435Q34289206-8259A0F7-9E4B-4B32-B23F-DDF18ECC719AQ34700675-E7F74B19-EF8E-4D4F-8E88-FE37CC989A0BQ35060321-1566BB90-10F5-4AA0-A998-136BD8CBB903Q35664923-6B73C838-29C4-4CE0-97CC-5E142B987313Q36242475-6F1E276F-F0AE-4353-BAF2-0C490D16A05EQ36714088-0D0C6A9C-1BD9-4D1C-B808-D1B6B5DF9C8FQ36752040-00026F54-CF28-4D11-B349-19E5991264B9Q36883848-0B3F4324-06BA-44C7-B04B-14B235771F6DQ37038276-421479DE-F5E7-480B-A915-646CFBA86CC5Q37109165-D4E80083-38E9-431B-8258-5D390A7E3A34Q37257768-4D4D434F-358A-467A-B025-CA506446EE41Q37390515-CC161ED3-7EE2-46C4-BD8C-2A36B4BBD363Q37559965-F7F01B40-EA46-4A6A-9C91-DDB63C79900FQ37595513-1542B295-EEA2-49CF-A5FF-707F5FE7DBD3Q37634052-18D526EC-2FEB-4BB2-B84C-8B9FB7B5D138Q37646333-BCD8643E-F531-45FC-90B8-29917161B410Q37667964-0B72904C-2DE5-4192-B199-C0ABEC4139FEQ37709902-9706946D-CDAE-41E3-850C-31D302CC7018Q37998754-F423E4F4-C3F3-4F5D-9655-D8680A960C4EQ38068966-E99094D8-7EE7-49AA-BFEB-B5BE2825EED0Q38116067-C44833CB-A58A-4698-9559-6D6C6FB0B30EQ38162129-9FA83997-C838-4DA9-AC8C-FF76C32590ACQ38800033-DBB84D65-5D25-4268-9C5D-3294221C52FDQ39308337-BC0A4F55-4553-4122-9803-A6A2D15CAC37Q39885205-48AE117C-7716-4E4E-A460-1B5FBDB9D15FQ40004825-CA48EC82-0B15-4521-A037-987F868B09C0Q40020449-F2513715-07D4-4F61-BC7F-FAD11533FDD8Q41127889-41B0AD4E-30E7-4B1F-95B2-0837F755ED4CQ41175045-5DD8E44C-4A50-43F4-B9EF-ECA82CEF6FD6Q41237376-4B050C18-A7C9-442F-8E70-6D74CFFC2990Q41888065-C6C407D4-B87D-4032-B28A-039DA69F660FQ41893614-0A02F871-86B3-4F0E-AC4A-3DE0AB0CED16Q42205916-3859B4C9-41A9-4347-8DC3-1248AF2253DB
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immunobiology of head and neck cancer.
@ast
Immunobiology of head and neck cancer.
@en
type
label
Immunobiology of head and neck cancer.
@ast
Immunobiology of head and neck cancer.
@en
prefLabel
Immunobiology of head and neck cancer.
@ast
Immunobiology of head and neck cancer.
@en
P1476
Immunobiology of head and neck cancer.
@en
P2093
Theresa L Whiteside
P2888
P304
P356
10.1007/S10555-005-5050-6
P577
2005-01-01T00:00:00Z